恩西地平是可口服,可逆,选择性的 IDH2 突变酶抑制剂,抑制IDH2R140Q 和 IDH2R172K 的 IC50 分别为100 和 400 nM,是一种药物,用于治疗复发或难治性急性髓细胞白血病患者中的异柠檬酸脱氢酶2(IDH2)基因的特异性突变。

清空选项
1650550-25-6 2-Methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol methanesulfonate
BD6326041650550-25-698%
¥2141.0050mg常备现货
155377-05-2 Methyl 6-(trifluoromethyl)picolinate
BD168783155377-05-297%
¥957.0025g常备现货
131747-42-7 6-(Trifluoromethyl)picolinic acid
BD110046131747-42-798%
¥379.0025g常备现货
2854-16-2 1-Amino-2-methylpropan-2-ol
BD563622854-16-298%
¥30.001g常备现货
147149-98-2 4-Amino-2-(trifluoromethyl)pyridine
BD74001147149-98-298%
¥29.00250mg常备现货
1446507-68-1 4-Chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine
BD7491271446507-68-197%
¥5983.001g常备现货
1446507-40-9 2,4-Dichloro-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazine
BD6829261446507-40-997%
¥13703.001g
1446507-38-5 6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
BD3040641446507-38-597%
¥1569.001g
1